Strontium ranelate: a novel mode of action leading to renewed bone quality (Q35971466)

11 August 2017

1 reference

title

Strontium ranelate: a novel mode of action leading to renewed bone quality (English)

1 reference

11 August 2017

1 reference

Patrick Ammann

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Osteoporosis International

11 August 2017

published in

1 reference

11 August 2017

volume

16 Suppl 1

1 reference

11 August 2017

page(s)

S11-5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-004-1809-9

11 August 2017

exact match

0 references

cites work

Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Mechanical and morphological variation of the human lumbar vertebral cortical and trabecular bone

1 reference

12 December 2020

Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study

1 reference

12 December 2020

Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy

1 reference

12 December 2020

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

1 reference

12 December 2020

Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats

1 reference

12 December 2020

High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency

1 reference

12 December 2020

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

1 reference

12 December 2020

Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation

1 reference

12 December 2020

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats

1 reference

12 December 2020

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

1 reference

12 December 2020

Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur

1 reference

12 December 2020

Growth hormone stimulates bone formation and strength of cortical bone in aged rats

1 reference

12 December 2020

PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats

1 reference

12 December 2020

Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats

1 reference

12 December 2020

Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications

1 reference

12 December 2020

S12911-2 reduces bone loss induced by short-term immobilization in rats

1 reference

12 December 2020

An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

1 reference

12 December 2020

Heterogeneity of bone lamellar-level elastic moduli

1 reference

12 December 2020

Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration

1 reference

12 December 2020

Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats

1 reference

12 December 2020

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

1 reference

12 December 2020

S 12911-2 inhibits osteoclastic bone resorption in vitro

1 reference

12 December 2020

Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone response

1 reference

12 December 2020

Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines

1 reference

12 December 2020

Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone

1 reference

12 December 2020

Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Sex steroids and the construction and conservation of the adult skeleton

1 reference

12 December 2020

Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum

1 reference

12 December 2020

Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis.

1 reference

12 December 2020

The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats

1 reference

12 December 2020

New developments in biochemical markers for osteoporosis

1 reference

12 December 2020

Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice

1 reference

12 December 2020

Age, gender, and bone lamellae elastic moduli.

1 reference

12 December 2020

Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride

1 reference

12 December 2020

10.1007/S00198-004-1809-9

Identifiers

DOI

1 reference

11 August 2017

1 reference